๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Zoledronic acid shows potential anticancer benefits

Book ID
120842284
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2008
Weight
121 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Anticancer effects of zoledronic acid ag
Anticancer effects of zoledronic acid against human osteosarcoma cells
โœ B. Kubista; K. Trieb; F. Sevelda; C. Toma; F. Arrich; P. Heffeter; L. Elbling; H ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 355 KB

## Abstract Based on neoadjuvant chemotherapy, the prognosis of osteosarcoma patients has improved dramatically. However, due to therapy resistance in patient subgroups, the development of new treatment strategies is still of utmost importance. The aim of our study was to test the effects of the ni

Cyr61 downmodulation potentiates the ant
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells
โœ Monica Marra; Daniele Santini; Giuseppina Meo; Bruno Vincenzi; Silvia Zappavigna ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 477 KB

## Abstract We have analyzed the gene modulation induced by zoledronic acid (ZOL) in androgenโ€resistant prostate cancer PC3 cells with cDNA microarray platform to identify new molecular targets of ZOL in prostate cancer. The gene coding for cysteineโ€rich, angiogenic inducer, 61 (CYR61) resulted hig